Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2023-11-01
|
| Series: | Blood Cancer Journal |
| Online Access: | https://doi.org/10.1038/s41408-023-00948-x |
| _version_ | 1797415975634599936 |
|---|---|
| author | Miao Wang Han-Yu Cao Kai-Wen Tan Qiao-Cheng Qiu Yuan-Hong Huang Shuai-shuai Ge Zi-Hao Wang Jia Chen Xiao-Wen Tang De-Pei Wu Sheng-Li Xue Zheng Li Hai-Ping Dai |
| author_facet | Miao Wang Han-Yu Cao Kai-Wen Tan Qiao-Cheng Qiu Yuan-Hong Huang Shuai-shuai Ge Zi-Hao Wang Jia Chen Xiao-Wen Tang De-Pei Wu Sheng-Li Xue Zheng Li Hai-Ping Dai |
| author_sort | Miao Wang |
| collection | DOAJ |
| first_indexed | 2024-03-09T05:57:14Z |
| format | Article |
| id | doaj.art-638f511fdb7145c0811514bbb3eea81b |
| institution | Directory Open Access Journal |
| issn | 2044-5385 |
| language | English |
| last_indexed | 2024-03-09T05:57:14Z |
| publishDate | 2023-11-01 |
| publisher | Nature Publishing Group |
| record_format | Article |
| series | Blood Cancer Journal |
| spelling | doaj.art-638f511fdb7145c0811514bbb3eea81b2023-12-03T12:12:15ZengNature Publishing GroupBlood Cancer Journal2044-53852023-11-011311410.1038/s41408-023-00948-xVenetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching studyMiao Wang0Han-Yu Cao1Kai-Wen Tan2Qiao-Cheng Qiu3Yuan-Hong Huang4Shuai-shuai Ge5Zi-Hao Wang6Jia Chen7Xiao-Wen Tang8De-Pei Wu9Sheng-Li Xue10Zheng Li11Hai-Ping Dai12National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow Universityhttps://doi.org/10.1038/s41408-023-00948-x |
| spellingShingle | Miao Wang Han-Yu Cao Kai-Wen Tan Qiao-Cheng Qiu Yuan-Hong Huang Shuai-shuai Ge Zi-Hao Wang Jia Chen Xiao-Wen Tang De-Pei Wu Sheng-Li Xue Zheng Li Hai-Ping Dai Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study Blood Cancer Journal |
| title | Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study |
| title_full | Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study |
| title_fullStr | Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study |
| title_full_unstemmed | Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study |
| title_short | Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study |
| title_sort | venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with runx1 runx1t1 a retrospective propensity score matching study |
| url | https://doi.org/10.1038/s41408-023-00948-x |
| work_keys_str_mv | AT miaowang venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy AT hanyucao venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy AT kaiwentan venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy AT qiaochengqiu venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy AT yuanhonghuang venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy AT shuaishuaige venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy AT zihaowang venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy AT jiachen venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy AT xiaowentang venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy AT depeiwu venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy AT shenglixue venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy AT zhengli venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy AT haipingdai venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy |